15th June 2017

MicroPharm Invests with Welsh Government Backing

Pharmaceutical company Micropharm is investing in new manufacturing clean room facilities in a move that has been supported by the Welsh Government.

The Newcastle Emlyn-based company develops immunotherapy products to target infectious diseases and acute toxic conditions. It currently produces two anti-venoms for the treatment of snakebites from the European common adder and the carpet viper in West Africa.

As part of a £2m expansion, which is supported by £150,000 from the Welsh Government, it will open new facilities at Cilgerran while retaining its existing Carmarthenshire base.

The investment is expected to create 15 jobs and safeguard a further 14, bringing the total headcount to 51.

Ian Cameron, MicroPharm’s chief executive, said: “We have outgrown our existing facilities in Newcastle Emlyn and the new manufacturing facility at Cilgerran will provide a platform for the long term growth of the company. The Welsh Government has supported the growth of MicroPharm since its inception and we are grateful for the continued support.”

Economy secretary Ken Skates added: “MicroPharm is a key contributor to Wales’ expertise and I am delighted Welsh Government support will enable its  planned expansion to go ahead immediately. The investment will provide the additional facilities required to meet the growing global demand for its products.

“It will also enable the company to capitalise on opportunities to increase its product range and support its on-going research to provide treatments for devastating diseases like clostridium difficile infection (CDI) and ebola.”

View Micropharm’s profile here.